JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.62% |
| 2 | Healthcare | 12.48% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Enpro
NPO
$7.12B
| $6.23M | ﹤0.01% |
73,339
-7,777
| -10% | -$707K |
|
2427
Texas Capital Bancshares
TCBI
$4.38B
| $6.23M | ﹤0.01% |
105,518
-2,328
| -2% | -$138K |
|
|
KDNY
2428
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $6.23M | ﹤0.01% |
316,831
+184,955
| +140% | +$3.71M |
|
2429
PUT
Green Plains
GPRE
$1.09B
| $6.23M | ﹤0.01% |
214,200
| – | – |
|
2430
Nu Skin
NUS
$236M
| $6.22M | ﹤0.01% |
186,537
+6,811
| +4% | +$284K |
|
2431
InvenTrust Properties
IVT
$2.59B
| $6.22M | ﹤0.01% |
291,652
+5,258
| +2% | +$140K |
|
2432
EnerSys
ENS
$6.81B
| $6.21M | ﹤0.01% |
106,847
+15,293
| +17% | +$974K |
|
|
VSXY
2433
Victoria's Secret
VSXY
$7.24B
| $6.21M | ﹤0.01% |
213,224
-59,137
| -22% | -$1.99M |
|
2434
RingCentral
RNG
$5.25B
| $6.21M | ﹤0.01% |
155,248
+101,832
| +191% | +$4.88M |
|
2435
TransAlta
TAC
$3.92B
| $6.2M | ﹤0.01% |
702,295
-134,642
| -16% | -$1.38M |
|
|
KAMN
2436
DELISTED
Kaman Corp
KAMN
| $6.19M | ﹤0.01% |
221,710
-27,185
| -11% | -$848K |
|
2437
PUT
Expeditors International
EXPD
$24B
| $6.18M | ﹤0.01% |
+70,000
| New | +$7.01M |
|
2438
CALL
Union Pacific
UNP
$174B
| $6.18M | ﹤0.01% |
31,700
+5,500
| +21% | +$1.22M |
|
2439
Amphastar Pharmaceuticals
AMPH
$858M
| $6.17M | ﹤0.01% |
219,683
+2,527
| +1% | +$82.5K |
|
2440
Array Technologies
ARRY
$796M
| $6.17M | ﹤0.01% |
371,822
-191,438
| -34% | -$3.31M |
|
|
SIRE
2441
DELISTED
Sisecam Resources LP
SIRE
| $6.16M | ﹤0.01% |
313,676
+195,266
| +165% | +$4.02M |
|
2442
DoubleLine Opportunistic Bond ETF
DBND
$757M
| $6.16M | ﹤0.01% |
135,000
-60,000
| -31% | -$2.86M |
|
2443
Navient
NAVI
$867M
| $6.16M | ﹤0.01% |
419,420
-496,752
| -54% | -$7.58M |
|
|
CGAU
2444
Centerra Gold
CGAU
$4.15B
| $6.13M | ﹤0.01% |
1,389,839
-177,417
| -11% | -$923K |
|
2445
Viper Energy
VNOM
$14.8B
| $6.13M | ﹤0.01% |
213,723
-43,217
| -17% | -$1.26M |
|
|
EGRX
2446
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.13M | ﹤0.01% |
231,806
+26,959
| +13% | +$989K |
|
2447
CALL
Oracle
ORCL
$450B
| $6.12M | ﹤0.01% |
100,200
-35,100
| -26% | -$2.57M |
|
2448
CALL
Edwards Lifesciences
EW
$53.6B
| $6.12M | ﹤0.01% |
74,000
+41,900
| +131% | +$4.03M |
|
2449
Simply Good Foods
SMPL
$968M
| $6.1M | ﹤0.01% |
190,718
+3,404
| +2% | +$112K |
|
2450
La-Z-Boy
LZB
$1.64B
| $6.08M | ﹤0.01% |
269,625
+7,797
| +3% | +$207K |
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 557 new, 2,573 increased, 2,584 reduced and 515 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 557 new positions and closed 515 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.